Allogene Therapeutics
ALLO
#8751
Rank
HK$1.70 B
Marketcap
HK$4.92
Share price
-5.88%
Change (1 day)
-48.60%
Change (1 year)

EPS for Allogene Therapeutics (ALLO)

EPS in 2026 (TTM): -HK$5.23

According to Allogene Therapeutics 's latest financial reports the company's current EPS (TTM) is -HK$5.25. In 2025 the company made an earnings per share (EPS) of -HK$6.82 an increase over its 2024 EPS that were of -HK$10.43.

EPS history for Allogene Therapeutics from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$5.23-23.28%
2025-HK$6.82-34.59%
2024-HK$10.43
2022-HK$18.1922.75%
2021-HK$14.81-9.13%
2020-HK$16.3014.92%
2019-HK$14.19-9.42%
2018-HK$15.66

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
-HK$10.58 101.49%๐Ÿ‡บ๐Ÿ‡ธ USA